Home
/ Genewiz
/ Competitors

Genewiz Competitors and Similar CompaniesClear all

UCB's competitors and similar companies include Verona Pharma and Fate Therapeutics.

	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.	Fate Therapeutics Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Founding Date	Founding Date 1928	Founding Date N/A	Founding Date 2007
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations London, GB HQ Cardiff, GB Raleigh, US	Locations San Diego, US HQ San Diego, US
Employees	Employees 9,052	Employees 79	Employees 17871% increase
Valuation ($)	Valuation ($) 34.3 b	Valuation ($) 2.7 b	Valuation ($) 309.7 m
Financial
Revenue (est.)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) $42.3m (FY, 2024)	Revenue (est.) $6.6m (FY, 2025)
Cost of goods	Cost of goods €1.4b (FY, 2025)	Cost of goods $1.4m (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit €7.2b (FY, 2025)	Gross profit $40.9m (FY, 2024)	Gross profit N/A
Net income	Net income €1.6b (FY, 2025)	Net income ($173.2m) (FY, 2024)	Net income ($136.3m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 11.5m	Total funding raised $ 330.2m